These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9184633)

  • 1. Expression of CD23 in the germinal center of thymus from myasthenia gravis patients.
    Murai H; Hara H; Hatae T; Kobayashi T; Watanabe T
    J Neuroimmunol; 1997 Jun; 76(1-2):61-9. PubMed ID: 9184633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer.
    Okumura M; Ohta M; Takeuchi Y; Shiono H; Inoue M; Fukuhara K; Kadota Y; Miyoshi S; Fujii Y; Matsuda H
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1922-8. PubMed ID: 14688707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
    Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
    J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active ectopic thymus predicts poor outcome after thymectomy in class III myasthenia gravis.
    Ambrogi V; Mineo TC
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):601-6. PubMed ID: 22177829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thymectomy and antibodies to acetylcholine receptors (AChR) in patients with myasthenia gravis in the early postoperative period].
    Nikishov VN; Bogdanov EI; Sanadze AG; Sigal EI; Sidnev DV; Dedaev SI; Kondrat'ev AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):32-6. PubMed ID: 23235409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis.
    Sims GP; Shiono H; Willcox N; Stott DI
    J Immunol; 2001 Aug; 167(4):1935-44. PubMed ID: 11489973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible role of CD5+ B cells expressing CD23 in mediating the elevation of serum-soluble CD23 in patients with rheumatoid arthritis.
    Ikizawa K; Yanagihara Y; Kajiwara K; Koshio T; Shida T; Yamada A
    Int Arch Allergy Immunol; 1993; 101(4):416-24. PubMed ID: 7689005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunopathology of myasthenia gravis.
    Lennon VA
    Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scenarios for autoimmunization of T and B cells in myasthenia gravis.
    Shiono H; Roxanis I; Zhang W; Sims GP; Meager A; Jacobson LW; Liu JL; Matthews I; Wong YL; Bonifati M; Micklem K; Stott DI; Todd JA; Beeson D; Vincent A; Willcox N
    Ann N Y Acad Sci; 2003 Sep; 998():237-56. PubMed ID: 14592881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymus involvement in early-onset myasthenia gravis.
    Cron MA; Maillard S; Villegas J; Truffault F; Sudres M; Dragin N; Berrih-Aknin S; Le Panse R
    Ann N Y Acad Sci; 2018 Jan; 1412(1):137-145. PubMed ID: 29125185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 3. The effect of thymectomy.
    Oosterhuis HJ; Limburg PC; Hummel-Tappel E; Van den Burg W; The TH
    J Neurol Sci; 1985 Jul; 69(3):335-43. PubMed ID: 4031948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesis.
    Roxanis I; Micklem K; McConville J; Newsom-Davis J; Willcox N
    J Neuroimmunol; 2002 Apr; 125(1-2):185-97. PubMed ID: 11960656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Receptor abnormalities and diseases. Myasthenia gravis and auto antibodies].
    Nishitani H
    Nihon Naika Gakkai Zasshi; 1987 Dec; 76(12):1814-8. PubMed ID: 3450771
    [No Abstract]   [Full Text] [Related]  

  • 15. The pathogenesis of myasthenia gravis--a hypothesis.
    Olanow CW; Roses AD
    Med Hypotheses; 1981 Jul; 7(7):957-68. PubMed ID: 7289911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No direct correlation between serum antiacetylcholine receptor antibody levels and clinical state of individual patients with myasthenia gravis.
    Roses AD; Olanow CW; McAdams MW; Lane RJ
    Neurology; 1981 Feb; 31(2):220-4. PubMed ID: 7193309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis and pathophysiology of myasthenia gravis--the role of thymus in myasthenia gravis (author's transl)].
    Ohshima F
    No To Shinkei; 1980 Sep; 32(9):909-19. PubMed ID: 7437164
    [No Abstract]   [Full Text] [Related]  

  • 18. Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis.
    Leprince C; Cohen-Kaminsky S; Berrih-Aknin S; Vernet-Der Garabedian B; Treton D; Galanaud P; Richard Y
    J Immunol; 1990 Oct; 145(7):2115-22. PubMed ID: 2144544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thymic lymphoid hyperplasia of myasthenia gravis patients: correlation with clinical features and efficacy of thymectomy].
    Yoshitake T; Takahama T; Kanai F; Ohnishi K; Tamura K; Suzuki T; Kametani Y; Kataoka D; Nakata H; Itoyama S
    Kyobu Geka; 1995 Jun; 48(6):447-51. PubMed ID: 7602854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.